ARCH Venture Management as of June 30, 2023
Portfolio Holdings for ARCH Venture Management
ARCH Venture Management holds 6 positions in its portfolio as reported in the June 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Eqrx | 41.7 | $68M | 36M | 1.86 | |
| Verve Therapeutics (VERV) | 23.3 | $38M | 2.0M | 18.75 | |
| Erasca (ERAS) | 18.8 | $31M | 11M | 2.76 | |
| Denali Therapeutics (DNLI) | 12.6 | $21M | 694k | 29.51 | |
| Singular Genomics Systems In | 1.9 | $3.2M | 3.8M | 0.83 | |
| Unity Biotechnology (UBX) | 1.6 | $2.6M | 1.0M | 2.55 |
